The global anti-infective vaccines market was valued at US$49.29 billion in 2020. The global market is expected to reach US$94.08 billion in 2026 from its previous value of US$54.26 billion in 2021

Global ePharmacy market was valued at US$68.65 billion in 2020 and is projected to reach at a market value of US$370.13 million by 2031

The global big data analytics in healthcare market is expected to reach US$45.64 billion in 202. Visiongain further anticipates that the global market will reach US$101.07 billion in 2031.

The global Anti-Infective Agents market was valued at US$ US$140.04 bn in 2021 and is projected to grow at a CAGR of 4.3% during the forecast period 2021-2031

The global single-use bioreactors market is estimated to be valued at US$3.46 billion in 2021. and market is projected to reach at a market value of US$5.17 billion by 2031

Global NGS Based RNA Sequencing market was valued at US$ 1999.6million in 2020 and is projected to reach at a market value of US$6874.2million by 2031.

The global cancer diagnostics market was estimated to be valued at US$45,106.5 million in2020 and is expected to reachUS$74,798.0 million in 2026

Global AI in Drug Discovery market was valued at US$ 230.4million in 2021 and is projected to reach at a market value of US$4,056.2 million by 2031

Global Protein Labelling Reagents for Research Use Only market was valued at US$ 2.71 billion in 2021 and is projected to reach a market value of US$ 4.25 billion by 2031

Global inhalation & nasal spray generic drugs market was valued at US$ US$7.67 bn in 2020 and is projected to grow at a CAGR of 8.29% during the forecast period 2021-2031

Global cell-based assay market was valued at US$ 15,927.5 million in 2020 and is projected to reach at a market value of US$ 35,033.9 million by 2030

The global point of care diagnostics market was valued at $32,945 million in 2020 and is projected to reach $73,293 million in 2031

The global rare disease market was valued at US$179.56 billion in 2021 and is expected to reach US$623.73 billion by 2031

The North American market for molecular diagnostics was valued at US$4,135.8 million in 2020 and is expected to reachUS$12,058.3 million by 2031

The worldwide demand for clinical laboratory tests is expected to rise at a lucrative US$421.06 billion by 2031 from its previous value of US$206.79 billion in 2021

The global respiratory inhalers market is estimated to be valued at US$33.41 billion in 2020 and is projected to reach at a market value of US$51.7 billion by 2031

overall anesthesia and respiratory business outlook. Also, significant growth during the COVID-19 pandemic

Global mental disorder drugs market was valued at US$ US$36.77 bn in 2020 and is projected to reach at a market value of US$58.91 billion by 2031

Global protein engineering market was valued at US$ 2,683.6 million in 2020 and is projected to reach at a market value of US$ 9,785.6 million by 2031

overall global dermatological drugs market? How much will this market be worth from 2021 to 2031

What is the current size of the overall global AI in Pharmaceuticals market? How much will this market be worth from 2021 to 2031

According to Visiongain analysis, the global biological drug API manufacturing services market is estimated to be valued at US$6,019.5 million in 2020. The market is expected to reach US$10,574.3 million in 2026

The Global non-alcoholic fatty liver disease & NAFLD market is estimated to be valued at US$17.43 billion in 2021 and is projected to reach at a market value of US$62.06 billion by 2031

Global macular degeneration drugs market was valued at US$ 19.18billion in 2020 and is projected to reach at a market value of US$ 40.16billion by 2031

Revenue forecasts to 2031 for 5 regional and 14 key national markets– See forecasts for the Vaccine Adjuvants market in North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

The Market is estimated to be worth US$212.7 million in 2020 and is projected to reach US$ 25,619.6 million in 2030

Visiongain further anticipates that the global CNS therapeutics market will reach US$ 180.3 billion in 2031

Animal Health Market size Estimated at US$89,325.2 Million by 2031

Global Virus Diagnostic Kits market size is projected to reach US$34.29 billion by 2031

Global Advanced Therapy Medicinal Products Market is projected to reach at market value of US$ 59.91 billion by 2031

In addition to revenue forecasting to 2030, our new study provides you with recent market development and future aspects such as Next Generation Sequencing Technology, Biopharmaceutical R&D Expenditure, Technological Advancement in Omics Research

Global plasma therapy market is estimated to be valued at US $298.7 million in 2020 and is projected to reach at a market value of US$816.5 million by 2031

Global food for special medical purpose market size, in terms of value, was worth the US $11.21 Bn in 2019. It is projected to reach the US $19.41 Bn by 2030

Visiongain’s analyst says: ‘Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

Global digital clinical supply chain market is anticipated to reach US$ 820.2 million in 2030 from its previous value of US$ 483.0 million in 2020

The global Amyotrophic Lateral Sclerosis market is anticipated to grow at a lucrative CAGR of more than 5.5% and anticipated to crossUSD 1,000.0 million by 2030

Global antiviral drugs treatment market was valued at US$ US$52.33 bn in 2020 and is projected to reach a market value of US$74.88 billion by 2031.

Visiongain has published a new report on Global inactivated Vaccines Market Report Forecast Between 2020 to 2030.

Global CBRN market was valued at US$ 9.0 billion in 2020 and is projected to reach a market value of US$ 15.5 billion by 2031.